| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Hercules Capital, Inc. | Director | Common Stock | 87,458 | $1,329,361 | $15.20 | 23 Feb 2026 | Direct |
| PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 30,000 | $55,669 | $2.08 | 05 Jun 2025 | Direct |
| ENVESTNET, INC. | Director | Common Stock | 0 | $0 | $63.15 | 25 Nov 2024 | By trust |
| ENVESTNET, INC. | Director | Common Stock | 0 | $0 | $63.15 | 25 Nov 2024 | Direct |
| ENVESTNET, INC. | Director | Stock Option (right to buy) | 0 | $0 | $15.34 | 25 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HTGC | Hercules Capital, Inc. | 23 Feb 2026 | 1 | +$100,320 | 4 | Director | 25 Feb 2026, 08:59 |
| HTGC | Hercules Capital, Inc. | 03 Nov 2025 | 1 | +$106,647 | 4 | Director | 04 Nov 2025, 17:32 |
| PLRX | PLIANT THERAPEUTICS, INC. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 20:42 |
| HTGC | Hercules Capital, Inc. | 08 May 2025 | 1 | +$104,923 | 4 | Director | 09 May 2025, 16:21 |
| /report/000121390024102152-crowell-gayle-a-2024-11-25 | ENVESTNET, INC. | 25 Nov 2024 | 3 | -$1,321,540 | 4 | Director | 25 Nov 2024, 16:05 |
| HTGC | Hercules Capital, Inc. | 06 Aug 2024 | 1 | +$104,592 | 4 | Director | 08 Aug 2024, 18:49 |
| HTGC | Hercules Capital, Inc. | 25 Jun 2024 | 1 | +$14,067 | 4 | Director | 26 Jun 2024, 16:57 |
| HTGC | Hercules Capital, Inc. | 20 Jun 2024 | 1 | +$59,994 | 4 | Director | 24 Jun 2024, 17:02 |
| PLRX | PLIANT THERAPEUTICS, INC. | 13 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 20:15 |
| /report/000162828024008494-crowell-gayle-a-2024-02-29 | ENVESTNET, INC. | 29 Feb 2024 | 1 | $0 | 4 | Director | 04 Mar 2024, 16:05 |
| HTGC | Hercules Capital, Inc. | 22 Nov 2023 | 2 | +$18,886 | 4 | Director | 27 Nov 2023, 20:06 |
| HTGC | Hercules Capital, Inc. | 08 Sep 2023 | 1 | +$89,930 | 4 | Director | 11 Sep 2023, 17:15 |
| HTGC | Hercules Capital, Inc. | 25 Aug 2023 | 2 | +$15,712 | 4 | Director | 28 Aug 2023, 17:04 |
| PLRX | PLIANT THERAPEUTICS, INC. | 07 Jun 2023 | 1 | $0 | 4 | Director | 08 Jun 2023, 17:11 |
| HTGC | Hercules Capital, Inc. | 23 May 2023 | 2 | +$14,851 | 4 | Director | 25 May 2023, 16:18 |
| HTGC | Hercules Capital, Inc. | 08 May 2023 | 1 | +$98,352 | 4 | Director | 09 May 2023, 16:17 |
| HTGC | Hercules Capital, Inc. | 09 Mar 2023 | 2 | +$14,439 | 4 | Director | 13 Mar 2023, 16:14 |
| /report/000162828023006124-crowell-gayle-a-2023-02-28 | ENVESTNET, INC. | 28 Feb 2023 | 1 | $0 | 4 | Director | 02 Mar 2023, 17:49 |
| HTGC | Hercules Capital, Inc. | 17 Nov 2022 | 2 | +$15,108 | 4 | Director | 21 Nov 2022, 15:07 |
| HTGC | Hercules Capital, Inc. | 16 Aug 2022 | 2 | +$14,357 | 4 | Director | 18 Aug 2022, 16:03 |
| HTGC | Hercules Capital, Inc. | 01 Aug 2022 | 1 | +$69,996 | 4 | Director | 01 Aug 2022, 16:42 |
| PLRX | PLIANT THERAPEUTICS, INC. | 16 Jun 2022 | 1 | $0 | 4 | Director | 21 Jun 2022, 16:16 |
| HTGC | Hercules Capital, Inc. | 24 May 2022 | 1 | +$11,042 | 4 | Director | 26 May 2022, 17:25 |
| HTGC | Hercules Capital, Inc. | 16 Mar 2022 | 1 | +$11,040 | 4 | Director | 18 Mar 2022, 16:07 |
| /report/000162828022004773-crowell-gayle-a-2022-02-28 | ENVESTNET, INC. | 28 Feb 2022 | 1 | $0 | 4 | Director | 02 Mar 2022, 19:47 |
| HTGC | Hercules Capital, Inc. | 17 Nov 2021 | 1 | +$9,029 | 4 | Director | 19 Nov 2021, 15:54 |
| HTGC | Hercules Capital, Inc. | 18 Aug 2021 | 1 | +$8,456 | 4 | Director | 19 Aug 2021, 16:49 |
| HTGC | Hercules Capital, Inc. | 02 Aug 2021 | 1 | +$69,987 | 4 | Director | 02 Aug 2021, 17:44 |
| PLRX | PLIANT THERAPEUTICS, INC. | 29 Jun 2021 | 1 | $0 | 4 | Director | 30 Jun 2021, 20:10 |
| HTGC | Hercules Capital, Inc. | 24 Jun 2021 | 1 | +$59,996 | 4 | Director | 28 Jun 2021, 16:03 |
| HTGC | Hercules Capital, Inc. | 19 May 2021 | 1 | +$5,257 | 4 | Director | 21 May 2021, 17:21 |